Home / Health / Atypical Parkinsonism: Faster, Deadlier Than Thought
Atypical Parkinsonism: Faster, Deadlier Than Thought
30 Mar
Summary
- Atypical Parkinsonism progresses faster, causing earlier disability than classic Parkinson's.
- Indian patients face late diagnosis due to low awareness and healthcare gaps.
- NIMHANS study reveals frequent misdiagnosis and poor management in India.
Atypical Parkinsonism, a set of neurological disorders that mimic Parkinson's disease, is progressing faster and leading to earlier disability in patients, according to emerging research from India. Unlike classic Parkinson's, these variants often respond poorly to standard treatments, complicating patient management.
A recent study by NIMHANS in Bengaluru reveals that Indian patients frequently experience misdiagnosis and inadequate care for these conditions. This delay is often due to limited awareness, a shortage of specialists, and diagnostic infrastructure gaps within India.
Key atypical Parkinsonism types include Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), Corticobasal Degeneration (CBD), and Dementia with Lewy Bodies (DLB). These conditions present distinct challenges, with symptoms like early balance problems, speech difficulties, and cognitive decline often appearing later.
Early detection is critical for improving patient outcomes, enabling better symptom management, and avoiding ineffective treatments. The NIMHANS study aims to develop advanced diagnostic tools, including genetic analysis and neuroimaging, to identify these conditions earlier and more accurately, particularly for underrepresented Indian populations.
